Axim Planning & Wealth’s Medpace MEDP Stock Holding History

Axim Planning & Wealth’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,047	Closed	-$588K	–	90
2025 Q4	$588K	Buy	+1,047	New	+$594K	0.62%	30

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Axim Planning & Wealth's MEDP Position: Q1 2026 in Review

Axim Planning & Wealth sold out of Medpace (MEDP) in Q1 2026, closing a stake of 1,047 shares — an estimated $588K sold.

Axim Planning & Wealth first reported a position in MEDP in Q4 2025 and held it in 1 quarter. The position peaked at $588K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Axim Planning & Wealth reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
Axim Planning & Wealth sold 1,047 Medpace shares in Q1 2026, an estimated $588K.
Axim Planning & Wealth first reported a position in Medpace in Q4 2025 and held it in 1 quarter.
Axim Planning & Wealth's Medpace position peaked at $588K in Q4 2025.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Axim Planning & Wealth's 13F filing for Q1 2026, filed 14 May 2026.